AGLE - Aeglea Biotherapeutics climbs 5.5% on ownership disclosure March, 08 2021 09:55 AM Aeglea BioTherapeutics Inc. Aeglea Biotherapeutics (AGLE) gains 5.5% premarket on disclosing 9.9% stake (4.9M shares) by Baker Bros.Source For further details see: Aeglea Biotherapeutics climbs 5.5% on ownership disclosure